Erin L. Wuebben

646 total citations
8 papers, 486 citations indexed

About

Erin L. Wuebben is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Erin L. Wuebben has authored 8 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Physiology. Recurrent topics in Erin L. Wuebben's work include Pluripotent Stem Cells Research (3 papers), CRISPR and Genetic Engineering (3 papers) and RNA modifications and cancer (2 papers). Erin L. Wuebben is often cited by papers focused on Pluripotent Stem Cells Research (3 papers), CRISPR and Genetic Engineering (3 papers) and RNA modifications and cancer (2 papers). Erin L. Wuebben collaborates with scholars based in United States and Hong Kong. Erin L. Wuebben's co-authors include Angie Rizzino, Jesse L. Cox, Phillip J. Wilder, Michael P. Washburn, Angie Rizzino, Joshua M. Gilmore, Sunil K. Mallanna, Michael A. Hollingsworth, Michel M. Ouellette and James A. Grunkemeyer and has published in prestigious journals such as PLoS ONE, Oncotarget and BMC Cancer.

In The Last Decade

Erin L. Wuebben

8 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erin L. Wuebben United States	8	380	149	131	53	33	8	486
Susanne Fransson Sweden	15	359 0.9×	126 0.8×	183 1.4×	39 0.7×	38 1.2×	38	542
Dailia B. Francis United States	4	323 0.8×	98 0.7×	90 0.7×	58 1.1×	25 0.8×	5	403
Angela Nakauka‐Ddamba United States	8	282 0.7×	169 1.1×	92 0.7×	88 1.7×	16 0.5×	8	429
Sue J. Hong United States	4	299 0.8×	177 1.2×	82 0.6×	56 1.1×	25 0.8×	11	466
Rose‐Marie Sjöberg Sweden	15	414 1.1×	141 0.9×	267 2.0×	88 1.7×	22 0.7×	16	629
Zhaodi Gu Japan	10	338 0.9×	103 0.7×	86 0.7×	44 0.8×	41 1.2×	18	395
Kai‐Oliver Henrich Germany	12	264 0.7×	95 0.6×	186 1.4×	47 0.9×	21 0.6×	13	443
Jayanti Jagannathan United States	5	426 1.1×	153 1.0×	226 1.7×	68 1.3×	22 0.7×	6	605
Tapan Ganguly United States	12	289 0.8×	132 0.9×	73 0.6×	98 1.8×	32 1.0×	23	543
Ana Hidalgo‐Sastre Germany	11	300 0.8×	123 0.8×	59 0.5×	82 1.5×	19 0.6×	14	444

Countries citing papers authored by Erin L. Wuebben

Since Specialization

Citations

This map shows the geographic impact of Erin L. Wuebben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin L. Wuebben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin L. Wuebben more than expected).

Fields of papers citing papers by Erin L. Wuebben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin L. Wuebben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin L. Wuebben. The network helps show where Erin L. Wuebben may publish in the future.

Co-authorship network of co-authors of Erin L. Wuebben

This figure shows the co-authorship network connecting the top 25 collaborators of Erin L. Wuebben. A scholar is included among the top collaborators of Erin L. Wuebben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin L. Wuebben. Erin L. Wuebben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wuebben, Erin L., Phillip J. Wilder, Jesse L. Cox, et al.. (2020). Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth. BMC Cancer. 20(1). 941–941. 13 indexed citations

2.

Wuebben, Erin L. & Angie Rizzino. (2017). The dark side of SOX2: cancer - a comprehensive overview. Oncotarget. 8(27). 44917–44943. 168 indexed citations

3.

Rizzino, Angie & Erin L. Wuebben. (2016). Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1859(6). 780–791. 97 indexed citations

4.

Wuebben, Erin L., Phillip J. Wilder, Jesse L. Cox, et al.. (2016). SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells. Oncotarget. 7(23). 34890–34906. 26 indexed citations

5.

Cox, Jesse L., Phillip J. Wilder, Erin L. Wuebben, et al.. (2014). Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Cancer Biology & Therapy. 15(8). 1042–1052. 28 indexed citations

6.

Cox, Jesse L., Phillip J. Wilder, Joshua M. Gilmore, et al.. (2013). The SOX2-Interactome in Brain Cancer Cells Identifies the Requirement of MSI2 and USP9X for the Growth of Brain Tumor Cells. PLoS ONE. 8(5). e62857–e62857. 81 indexed citations

7.

Wuebben, Erin L., et al.. (2013). Sox2 Expression Is Regulated by a Negative Feedback Loop in Embryonic Stem Cells That Involves AKT Signaling and FoxO1. PLoS ONE. 8(10). e76345–e76345. 31 indexed citations

8.

Wuebben, Erin L., Sunil K. Mallanna, Jesse L. Cox, & Angie Rizzino. (2012). Musashi2 Is Required for the Self-Renewal and Pluripotency of Embryonic Stem Cells. PLoS ONE. 7(4). e34827–e34827. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact